GLP-1 Drug Liraglutide Prevents Lupus-Associated Lung Hemorrhage in Mouse Model
Liraglutide prevented lupus-associated diffuse alveolar hemorrhage by inhibiting inflammatory signaling pathways, demonstrating GLP-1 drug repurposing for autoimmune lung complications.
Quick Facts
What This Study Found
Liraglutide prevented lupus-associated DAH in a mouse model by inhibiting inflammatory signaling pathways, demonstrating novel autoimmune lung protection by a GLP-1 RA.
Key Numbers
How They Did This
Lupus-associated DAH mouse model treated with liraglutide, with assessment of lung hemorrhage, inflammatory pathway analysis, and mechanistic characterization.
Why This Research Matters
Lupus DAH is often fatal with few treatments. A widely available GLP-1 drug could save lives if confirmed in human studies.
The Bigger Picture
GLP-1 drugs'anti-inflammatory properties extend to autoimmune lung disease — expanding their therapeutic potential beyond metabolism.
What This Study Doesn't Tell Us
Mouse model. Lupus is complex — mouse models don't fully replicate human disease. Prevention vs treatment distinction important.
Questions This Raises
- ?Would liraglutide help human lupus DAH patients?
- ?Should lupus patients on GLP-1 drugs be monitored for reduced DAH risk?
- ?Could GLP-1 drugs treat other lupus complications?
Trust & Context
- Key Stat:
- Lupus lungs protected A widely available diabetes drug prevented the life-threatening lung hemorrhage complication of lupus in a mouse model
- Evidence Grade:
- Preclinical mouse model. Important proof-of-concept for novel GLP-1 autoimmune indication.
- Study Age:
- Published in 2025.
- Original Title:
- Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.
- Published In:
- Journal of translational autoimmunity, 12, 100349 (2026)
- Authors:
- Jiang, Li, He, Liting, Li, Duo, Luo, Xin, Yang, Ming, Wu, Haijing, Long, Hai
- Database ID:
- RPEP-15384
Evidence Hierarchy
Frequently Asked Questions
Can GLP-1 drugs help lupus?
In mice, liraglutide prevented a dangerous lupus lung complication (diffuse alveolar hemorrhage) by suppressing inflammation. Human studies are needed to confirm this benefit.
Why would a diabetes drug help autoimmune disease?
GLP-1 drugs have powerful anti-inflammatory properties that extend far beyond blood sugar control. These effects may suppress the autoimmune inflammation driving lupus complications.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15384APA
Jiang, Li; He, Liting; Li, Duo; Luo, Xin; Yang, Ming; Wu, Haijing; Long, Hai. (2026). Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.. Journal of translational autoimmunity, 12, 100349. https://doi.org/10.1016/j.jtauto.2026.100349
MLA
Jiang, Li, et al. "Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.." Journal of translational autoimmunity, 2026. https://doi.org/10.1016/j.jtauto.2026.100349
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide prevents lupus-associated diffuse alveolar hemor..." RPEP-15384. Retrieved from https://rethinkpeptides.com/research/jiang-2026-liraglutide-prevents-lupusassociated-diffuse
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.